European Union
The judgments, involving Novartis and Bayer, centred on whether EU law allowed parallel importers to entirely repackage medicines
Christian Archambeau, executive director of the EUIPO, looks back at 2022 and addresses the expected drop in EUTM filings
Robert Reading of Clarivate examines years’ worth of trademark data in the EU and US, predicting what it might mean for brands
A tweak to the Rules of Procedure could theoretically make patents outside the Unified Patent Court’s jurisdiction subject to its rulings
Sponsored
Sponsored
-
Sponsored by Bird & BirdRoman Brtka of Bird & Bird comments on the Ferrari Front Kit case and explains the practical consequences for manufacturers that want to protect a part of a product independently of the whole product -
Sponsored by MaiwaldSusanna Heurung of Maiwald examines a decision by the European Court of Justice concerning the ending of a period of ‘acquiescence’ in a trademark case and what it means for potential plaintiffs
-
Sponsored by Bugnion SpACristina Biggi of Bugnion shares her expertise on second medical use patents in Europe, focusing particularly on recent case law from Italy
